B 3.2 J Bipolar Atrial "J" Lead
Navigation Links
B 3.2 J Bipolar Atrial "J" Lead
| Products | B 3.2 J Bipolar Atrial "J" Lead |
| Company | CCC |
| Item | B 3.2 J Bipolar Atrial "J" Lead |
| Features | Platinum with textured surface tip material. Tines endocardical fixation. |
| Description | Bipolar Atrial "J" Lead |
| Info | CCC Customer Service: (598-2) 600 7629 Web site: http://www.ccc.com.uy |
Related medicine products :
1. Disposable Bipolar Pencil - 18 Gauge Curved
2. Disposable Bipolar Pencil - 18 Gauge Straight
3. Disposable Bipolar Pencil - 23 Gauge Tapered Tip
4. McPherson Straight Bipolar Forceps
5. McCullough Bipolar Forceps
6. Bipolar Coaptation Forceps
7. Jeweler Type Bipolar Insulated Forceps
8. Cozean Bipolar Forceps
9. Tenzel Bipolar Forceps
10. Shepard Bipolar Forceps Angled
11. Osher Bipolar Coaptation Forceps
Breaking Medicine News(10 mins):Health News:City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans 2Health News:City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans 3Health News:City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans 4Health News:City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans 5Health News:Lilly Announces the First 300-unit Vial of Insulin 2Health News:Lilly Announces the First 300-unit Vial of Insulin 3Health News:Lilly Announces the First 300-unit Vial of Insulin 4Health News:Health Care Without Harm Applauds EPA Finding Climate Change is Danger to Public Health 2Health News:Health Care Without Harm Applauds EPA Finding Climate Change is Danger to Public Health 3Health News:Prostate Hormone Therapy May Up Heart Risks 2Health News:Prostate Hormone Therapy May Up Heart Risks 3Health News:New approach to sickle-cell disease shows promise in mice 2
[0] City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans[0] Lilly Announces the First 300-unit Vial of Insulin[0] Health Care Without Harm Applauds EPA Finding Climate Change is Danger to Public Health[0] Prostate Hormone Therapy May Up Heart Risks[1] New approach to sickle-cell disease shows promise in mice
Other Medicine News:Health News:Prescription labels geared toward pharmacies, not patients 2Health News:New HIV diagnoses rising in New York City among young men who have sex with men 2Health News:New HIV diagnoses rising in New York City among young men who have sex with men 3Health News:New HIV diagnoses rising in New York City among young men who have sex with men 4Health News:Additional Top Tier Institutions Implement Mediware's HCLL(TM) Transfusion Management Software 2Health News:Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc. 2Health News:Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc. 3Health News:Siemens Congratulates Kenneth R. Bertka, M.D., Recipient of 2007 AMDIS Award 2Health News:Siemens Congratulates Kenneth R. Bertka, M.D., Recipient of 2007 AMDIS Award 3Health News:Siemens Congratulates Kenneth R. Bertka, M.D., Recipient of 2007 AMDIS Award 4Health News:New Study of Aspartame Research Reaffirms Safety, Even Among Heaviest Users 2Health News:New Study of Aspartame Research Reaffirms Safety, Even Among Heaviest Users 3
Prescription labels geared toward pharmacies, not patientsNew HIV diagnoses rising in New York City among young men who have sex with menAdditional Top Tier Institutions Implement Mediware's HCLL(TM) Transfusion Management SoftwareCrystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.Siemens Congratulates Kenneth R. Bertka, M.D., Recipient of 2007 AMDIS AwardNew Study of Aspartame Research Reaffirms Safety, Even Among Heaviest Users
Breaking Medicine Technology:Elusys Presents Data From Anthim(R) Anthrax Anti-Toxin Studies at the HHS Stakeholders Workshop 2009 & BARDA Industry Day 2Elusys Presents Data From Anthim(R) Anthrax Anti-Toxin Studies at the HHS Stakeholders Workshop 2009 & BARDA Industry Day 3Amgen Board Authorizes $5 Billion Increase in Stock Repurchase Program 2Amgen Board Authorizes $5 Billion Increase in Stock Repurchase Program 3Genoptix Announces Participation at Deutsche Bank 2009 MedTools Investor Conference 2Reportlinker Adds Emerging Clinical Trial Locations India 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 62397 1Reportlinker Adds Emerging Clinical Trial Locations India 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 62397 2Reportlinker Adds Emerging Clinical Trial Locations India 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 62397 3Reportlinker Adds Emerging Clinical Trial Locations India 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 62397 4Reportlinker Adds Emerging Clinical Trial Locations India 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 62397 5Reportlinker Adds Emerging Clinical Trial Locations India 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 62397 6Reportlinker Adds Emerging Clinical Trial Locations India 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 62397 7Scientist Who Helps Explain Pain Wins Grawemeyer Award 62392 1Scientist Who Helps Explain Pain Wins Grawemeyer Award 62392 2Patient Safety Technologies Inc Appoints Marc L Rose CPA 28PA 29 Chief Financial Officer 6662 1Patient Safety Technologies Inc Appoints Marc L Rose CPA 28PA 29 Chief Financial Officer 6662 2
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |